CMAMIL: Cross-modality aligned multi-instance learning for label-free lung cancer immunotherapy response prediction
Authors:
- Zhaoyi YeZYZhaoyi Ye
- Congkuan SongCSCongkuan Song
- Yueyun WengYWYueyun Weng
- Hui ShenHSHui Shen
- Du WangDWDu Wang
- Liye MeiLMLiye Mei
- Cheng LeiCLCheng Lei
- 13 April 2026
- journal article
- Published by Elsevier in Optics and Lasers in Engineering
- Vol. 203
Abstract
No abstract availableFunding Information
- Department of Science and Technology of Hubei Province (Q20241403)
- National Key Research and Development Program of China (2023YFF0723300)
- Shenzhen Science and Technology Innovation Program (JCYJ20230807090207014)
- Natural Science Foundation of Hubei Province (2025AFB055)
- Hubei University of Technology
- National Natural Science Foundation of China (62475198 62505232)
This publication has 32 references indexed in Scilit:
- A computer-assisted medical diagnosis system for cancer diseases based on quaternion orthogonal Rademacher-Fourier moments and deep learningBiomedical Signal Processing and Control, 2025
- HAMIL : Hierarchical Attention Multi‐Instance Learning for Label‐Free Colorectal Cancer TypingMicroscopy Research and Technique, 2025
- Non-invasive biomarkers in lung cancerClinica Chimica Acta, 2025
- Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancerCancer, 2025
- Recent advances in lung cancer research: unravelling the future of treatmentUpdates in Surgery, 2024
- Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockadeCancer Cell, 2024
- Tumor mutational burden as a predictive biomarker for non-small cell lung cancer treated with immune checkpoint inhibitors of PD-1/PD-L1Clinical and Translational Oncology, 2024
- A phenotypic signature that identifies neoantigen-reactive T cells in fresh human lung cancersCancer Cell, 2022
- LeuFeatx: Deep learning–based feature extractor for the diagnosis of acute leukemia from microscopic images of peripheral blood smearComputers in Biology and Medicine, 2022
- Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancerAnnals of Oncology, 2022